Jiangxi Fushine Pharmaceutical (300497.SZ) establishes a wholly-owned subsidiary, Fuxiang (Fuyu) Biotechnology.
Fushixiang Pharmaceuticals (300497.SZ) announcement, the company has established Fushixiang (Wealthy) Biotechnology Limited with its own funds.
Jiangxi Fushine Pharmaceutical (300497.SZ) announced that the company has established Fuxiang (Fuyu) Biological Technology Co., Ltd. with its own funds, with a registered capital of 50 million yuan. Recently, Fuxiang (Fuyu) Biological Technology Co., Ltd. has completed the industrial and commercial registration procedures and obtained the "Business License" issued by the Fuyu County Market Supervision Administration.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
